Menu

GlobeImmune, Inc. GBIM

Full chart Compare
Set alert

Price alert · GBIM

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.000001 Day range 0.000001
0.000001 52-week range 0.0401
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Revenue → Gross Profit: $3.81MGross Profit → Expenses: $3.81MRevenue → Cost of Revenue: $2.65MExpenses → Selling, General & Admin: $4.55MExpenses → Research & Development: $1.84MExpenses → Other Operating Expenses: $187.34KNet Loss → Expenses: $2.77MGross Profit$3.81MNet Loss$2.77MCost of Revenue$2.65MExpenses$6.58MSelling, General & Admin$4.55MResearch & Development$1.84MOther Operating Expenses$187.34KRevenue$6.46M

Latest period ending Dec 31, 2015 · select a line to chart its full history

GBIM annual income statement
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
6.46M5.97M22.52M14.64M5.11M
3.81M974.17K13.49M4.61M-3.27M
-2.77M-5.82M7.69M-3.97M-12.59M
-2.77M-16.26M9.48M-2.01M-13.72M
-0.48-8.04-36.84-157.97-285.04
GBIM annual balance sheet
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
9.90M16.81M6.02M2.00M—
11.51M18.37M7.42M4.24M—
8.52M12.76M19.06M25.57M—
2.99M5.60M-199.32M-196.12M—
GBIM annual cash flow
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
-7.13M-10.05M3.93M-13.07M-5.01M
217.96K-166.85K-12.23K-108.83K-132.75K
217.96K-166.85K-12.23K-108.83K-132.75K
-6.91M10.89M3.92M-13.15M-5.14M